Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 116


Information needs of mothers regarding communicating BRCA1/2 cancer genetic test results to their children.

Tercyak KP, Peshkin BN, Demarco TA, Patenaude AF, Schneider KA, Garber JE, Valdimarsdottir HB, Schwartz MD.

Genet Test. 2007 Fall;11(3):249-55.


Parenting through genetic uncertainty: themes in the disclosure of breast cancer risk information to children.

Sharff ME, DeMarco TA, Mays D, Peshkin BN, Valdimarsdottir HB, Garber JE, Schneider KA, Patenaude AF, Tercyak KP.

Genet Test Mol Biomarkers. 2012 May;16(5):376-82. doi: 10.1089/gtmb.2011.0154. Epub 2011 Nov 15.


On the development of a decision support intervention for mothers undergoing BRCA1/2 cancer genetic testing regarding communicating test results to their children.

Peshkin BN, Demarco TA, Tercyak KP.

Fam Cancer. 2010 Mar;9(1):89-97. doi: 10.1007/s10689-009-9267-3. Epub 2009 Jul 17.


Distress and the parenting dynamic among BRCA1/2 tested mothers and their partners.

Mays D, DeMarco TA, Luta G, Peshkin BN, Patenaude AF, Schneider KA, Garber JE, Tercyak KP.

Health Psychol. 2014 Aug;33(8):765-73. doi: 10.1037/a0033418. Epub 2013 Jun 24.


Brief assessment of parents' attitudes toward testing minor children for hereditary breast/ovarian cancer genes: development and validation of the Pediatric BRCA1/2 Testing Attitudes Scale (P-TAS).

Peshkin BN, DeMarco TA, Garber JE, Valdimarsdottir HB, Patenaude AF, Schneider KA, Schwartz MD, Tercyak KP.

J Pediatr Psychol. 2009 Jul;34(6):627-38. doi: 10.1093/jpepsy/jsn033. Epub 2008 Apr 1.


Cognitive and emotional factors predicting decisional conflict among high-risk breast cancer survivors who receive uninformative BRCA1/2 results.

Rini C, O'Neill SC, Valdimarsdottir H, Goldsmith RE, Jandorf L, Brown K, DeMarco TA, Peshkin BN, Schwartz MD.

Health Psychol. 2009 Sep;28(5):569-78. doi: 10.1037/a0015205.


Prevalence and correlates of mothers and fathers attending pretest cancer genetic counseling together.

Demarco TA, Nusbaum RH, Peshkin BN, Patenaude AF, Schneider KA, Garber JE, Valdimarsdottir HB, Tercyak KP.

Patient Educ Couns. 2010 Jan;78(1):29-33. doi: 10.1016/j.pec.2009.05.013. Epub 2009 Jul 9.


Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.

Lerman C, Biesecker B, Benkendorf JL, Kerner J, Gomez-Caminero A, Hughes C, Reed MM.

J Natl Cancer Inst. 1997 Jan 15;89(2):148-57.


Decisional outcomes of maternal disclosure of BRCA1/2 genetic test results to children.

Tercyak KP, Mays D, DeMarco TA, Peshkin BN, Valdimarsdottir HB, Schneider KA, Garber JE, Patenaude AF.

Cancer Epidemiol Biomarkers Prev. 2013 Jul;22(7):1260-6. doi: 10.1158/1055-9965.EPI-13-0198.


Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not.

Katapodi MC, Northouse L, Pierce P, Milliron KJ, Liu G, Merajver SD.

Oncol Nurs Forum. 2011 Sep;38(5):572-81. doi: 10.1188/11.ONF.572-581.


Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations: a qualitative study of patient preferences.

Hurley K, Rubin LR, Werner-Lin A, Sagi M, Kemel Y, Stern R, Phillips A, Cholst I, Kauff N, Offit K.

Cancer. 2012 Dec 15;118(24):6270-7. doi: 10.1002/cncr.27695. Epub 2012 Jun 26.


Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey.

Di Prospero LS, Seminsky M, Honeyford J, Doan B, Franssen E, Meschino W, Chart P, Warner E.

CMAJ. 2001 Apr 3;164(7):1005-9.


BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationships.

McInerney-Leo A, Biesecker BB, Hadley DW, Kase RG, Giambarresi TR, Johnson E, Lerman C, Struewing JP.

Am J Med Genet A. 2005 Mar 1;133A(2):165-9.


BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling intervention.

McInerney-Leo A, Biesecker BB, Hadley DW, Kase RG, Giambarresi TR, Johnson E, Lerman C, Struewing JP.

Am J Med Genet A. 2004 Oct 15;130A(3):221-7.


Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients.

Schwartz MD, Lerman C, Brogan B, Peshkin BN, Halbert CH, DeMarco T, Lawrence W, Main D, Finch C, Magnant C, Pennanen M, Tsangaris T, Willey S, Isaacs C.

J Clin Oncol. 2004 May 15;22(10):1823-9. Epub 2004 Apr 5.


An exploration of the communication preferences regarding genetic testing in individuals from families with identified breast/ovarian cancer mutations.

Ratnayake P, Wakefield CE, Meiser B, Suthers G, Price MA, Duffy J; Kathleen Cuningham National Consortium for Research into Familial Breast Cancer, Tucker K.

Fam Cancer. 2011 Mar;10(1):97-105. doi: 10.1007/s10689-010-9383-0.


Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.

Bluman LG, Rimer BK, Regan Sterba K, Lancaster J, Clark S, Borstelmann N, Iglehart JD, Winer EP.

Psychooncology. 2003 Jul-Aug;12(5):410-27.


Psychological issues among children of hereditary breast cancer gene (BRCA1/2) testing participants.

Tercyak KP, Peshkin BN, Streisand R, Lerman C.

Psychooncology. 2001 Jul-Aug;10(4):336-46.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk